CRVL Corvel Corp.

CERIS Announces Innovations in Artificial Intelligence and Machine Learning That Improve Payment Integrity

CERIS Announces Innovations in Artificial Intelligence and Machine Learning That Improve Payment Integrity

Generative AI advances claim efficiency and accuracy

FORT WORTH, Texas, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Advancements in artificial intelligence (AI) and machine learning (ML) are significantly improving results and efficiencies for payment integrity in medical claims, according to CERIS, a CorVel company.

“CERIS leads the industry in leveraging AI and ML to automate tasks for greater efficiency and accuracy, to find patterns that may indicate fraud or systemic errors, to interpret medical language, and to summarize large amounts of information into actionable data,” said Steve Sutherland, Senior Vice President of Information Systems for CERIS, a Fort Worth-based company that has pioneered the use of this technology for payment integrity.

Sutherland notes, “Now, generative AI and machine learning are taking productivity and savings even further. For example, by efficiently using machine learning, we can more effectively identify claim combinations with high probability of upcoding, flagging them for review by the claim professionals. We can summarize medical documents, extract keywords, answer specific questions, and bring often overlooked items to the reviewer's attention. As a result, payers can more efficiently pay medical bills that are accurate and appropriate for the claim.”

Already, optical character recognition (OCR) and document extraction have increased throughput significantly. Additional benefits to CERIS clients include improved accuracy, faster turnaround time, and increased savings ratios.

Incorporating this technology also allows review teams to spend less time on tedious manual analysis so that they can focus on higher-value, more enriching work that better serves client needs. By making their work more rewarding and meaningful, valuable employees have higher job satisfaction and are more engaged, improving employee retention. CERIS’ leadership in technology elevates the efforts of professional staff and improves the outcomes delivered to clients.

Speed and precision are essential for maintaining payment integrity in healthcare, where payers have a responsibility to promptly and accurately reimburse providers, thus avoiding time-consuming efforts to recover erroneous payments. Prepayment review is becoming the norm – making it even more important to determine if a bill is accurate in a timely manner. Utilizing these new technologies improves the process and the experience of payers and providers.

About CERIS

CERIS, a leader in both prospective and retrospective claims review and repricing, combines clinical expertise and cost containment solutions to ensure the accuracy and transparency in healthcare payments. Accuracy and validation services include itemization review, DRG validation, facility repricing, contract and policy applications, review of implants and devices, and primary payer cost avoidance. Its universal chargemaster contains billions of charge items from more than 97% of the nation’s hospitals, helping to ensure the accuracy and objectivity of each claim review.

Contact: Melissa Storan

Phone: 949-851-1473



EN
14/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Corvel Corp.

 PRESS RELEASE

CorVel Announces Revenues and Earnings

CorVel Announces Revenues and Earnings FORT WORTH, Texas, Feb. 03, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and year ended December 31, 2025. Revenues for the nine months ended December 31, 2025 were $710 million, a 7% increase from $664 million during the nine months ended December 31, 2024. Earnings per share for the nine months ended December 31, 2025 were $1.53, up 16% compared to $1.32 during the nine months ended December 31, 2024. Revenues for the quarter were $236 million, an increase from $228 million in the December quarter...

 PRESS RELEASE

CorVel Corporation to Host Live Earnings Release Webcast

CorVel Corporation to Host Live Earnings Release Webcast FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, February 3, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel’s financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer. The ev...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Sarah Scott Named to Business Insurance’s “Women to Watch” List for 20...

Sarah Scott Named to Business Insurance’s “Women to Watch” List for 2025 Scott recognized for improving patient care and advancing innovation in workers’ compensation at CorVel FORT WORTH, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation is proud to announce that Sarah Scott, Executive Vice President of Product and Corporate Services, has been named to ’s prestigious “Women to Watch” list for 2025. Now celebrating its 20th year, the award honors women who have achieved extraordinary success in insurance and risk management through leadership, innovation, and mentorship. A 26...

Corvel Corp: 1 director

A director at Corvel Corp sold 7,286 shares at 76.921USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch